David J. Inwards

Hematology
5716 Cleveland St Ste 200
Virginia Beach, VA 23462

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications

Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy.

Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy.

Journal: Transplantation and cellular therapy
Published: April 25, 2024

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.

Journal: Blood
Published: January 18, 2024

Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy.

Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy.

Journal: Haematologica
Published: November 18, 2023

COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients.

COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients.

Journal: Scientific reports
Published: September 22, 2023

Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy.

Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy.

Journal: Blood advances
Published: August 27, 2023

Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.

Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.

Journal: Blood cancer journal
Published: July 12, 2023

Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.

Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.

Journal: Blood advances
Published: May 16, 2023

Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.

Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.

Journal: Haematologica
Published: April 07, 2023

Central nervous system involvement by mantle cell lymphoma.

Central nervous system involvement by mantle cell lymphoma.

Journal: Leukemia & lymphoma
Published: November 23, 2022

Outcomes of Older Adults with Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Mayo Clinic Cohort Analysis.

Outcomes of Older Adults with Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Mayo Clinic Cohort Analysis.

Journal: Transplantation and cellular therapy
Published: October 26, 2022

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.

Journal: Blood advances
Published: October 24, 2022

High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course.

High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course.

Journal: JCO oncology practice
Published: October 14, 2022
Showing 1-12 of 127

Last Updated: 09/26/2026